Pfizer is always open to Australia though they've got toes dipped in a few Aus-Bio's through either/or patnerships & stock holdings.
I guess the most likely candidate to look for would be the big pharma that is most highly focussed on the relevant disease area. Or of course threatened by any new potentially superior treatment.
End of year will tell the story make or break - hopefully not a Teva outcome all over again.
our cornerstone investor, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
